lorlatinib
pfizer,eli lilly
['crown', 'sclc', 'lung', 'thank you', 'nsclc', 'commit', 'pfizer']
thank you to all who attended our #asco22 crown data presentations highlighting critical research for people with alk+ metastatic #nsclc. we are committed to delivering breakthroughs that change the lives of people living with #lungcancer. learn more: 
News and information for healthcare professionals about Pfizer’s presence at scientific congresses. Please read: https://t.co/xwMAFDI5j5